Convatec GroupLSE:CTEC -0.09%77 OCF Yield % is 8.45 as of Jun. 28, 2026, which is 40% above its 10-year median of 6.02. GuruFocus rates LSE:CTEC with a GF Score™ of 77/100 and a GF Value™ of £2.55 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 852 Medical Devices & Instruments companies, Convatec Group ranks better than 81.22% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Convatec Group's OCF Yield % or its related term are showing as below:
LSE:CTEC'
s OCF Yield % Range Over the Past 10 Years
Min: 1.27 Med: 6.02 Max: 11.98
Current: 8.45
During the past 13 years, the highest OCF Yield % of Convatec Group was 11.98%. The lowest was 1.27%. And the median was 6.02%.
LSE:CTEC's OCF Yield % is ranked better than 81.22% of 852
companies
in the Medical Devices & Instruments industry
Industry Median: 1.785
vs LSE:CTEC: 8.45
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Convatec Group OCF Yield % Related Terms
Convatec Group OCF Yield % Historical Data
* Premium members only.
The historical data trend for Convatec Group's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LSE:CTEC vs ISRG, BDX, MDLN: OCF Yield % Comparison
For the Medical Instruments & Supplies subindustry, Convatec Group's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Convatec Group OCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Convatec Group's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Convatec Group's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Convatec Group (LSE:CTEC) has a OCF Yield % of 8.45 as of Jun. 28, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Convatec Group and its competitors. This is 40% above median its historical median of 6.02. Over the past decade, Convatec Group's OCF Yield % has ranged from 1.27 to 11.98. According to the industry distribution chart, Convatec Group ranks #160 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 18.8%.
Is Convatec Group's OCF Yield % too high?
Convatec Group's current OCF Yield % of 8.45 is 40% above median its 10-year median of 6.02. Over the past 10 years, this metric has ranged from a low of 1.27 to a high of 11.98. The Medical Devices & Instruments industry median OCF Yield % is 1.79. Convatec Group's value of 8.45 is 373.4% above this industry median. Based on the distribution chart, Convatec Group ranks #160 out of 852 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Convatec Group has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Convatec Group's OCF Yield % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Convatec Group ranks #160 out of 852 companies for OCF Yield %. This places Convatec Group in the top 19% of its industry — outperforming the majority of peers. The industry median OCF Yield % is 1.79. Convatec Group's value of 8.45 is 373.4% above this benchmark. Historically, Convatec Group's own OCF Yield % has ranged from 1.27 to 11.98 over the past decade. While the company's 10-year median is 6.02 vs. the industry median of 1.79, Convatec Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Devices & Instruments company?
The median OCF Yield % among Medical Devices & Instruments companies is 1.79, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Convatec Group's current OCF Yield % of 8.45 is 373.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Convatec Group and its competitors. For the Medical Devices & Instruments industry, the median OCF Yield % is 1.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Convatec Group's current OCF Yield % is 8.45, which is 40% above median its own 10-year median of 6.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Convatec Group stock overvalued right now?
Based on GuruFocus' analysis, Convatec Group (LSE:CTEC) is currently considered Modestly Undervalued. The stock's GF Value™ is £2.55, compared to a current price of £2.12 — trading 17% below its estimated fair value. The current OCF Yield % is 8.45, which is 40% above median its 10-year median of 6.02 and 373.4% above the Medical Devices & Instruments industry median of 1.79. Convatec Group's overall GF Score™ is 77/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Convatec Group (LSE:CTEC), the current OCF Yield % is 8.45 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Convatec Group (LSE:CTEC) Overvalued in 2026?
Based on GuruFocus' analysis, Convatec Group stock appears to be undervalued.
The current stock price of £2.12 is trading 17% below its estimated GF Value™ of £2.55.
GuruFocus considers Convatec Group to be Modestly Undervalued.
Key valuation signals for LSE:CTEC:
OCF Yield %: 8.45 (40% above median its 10-year median of 6.02)
GF Value™: £2.55 vs. price of £2.12 (17% below fair value)
Industry Position: 373.4% above the Medical Devices & Instruments median (#160 of 852)
No single metric tells the full story. See the LSE:CTEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Originally spun out of Bristol-Myers Squibb, Convatec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings. Advanced wound care and ostomy supplies are the largest divisions, accounting for 32% and 28% of total revenue, respectively. Continence care has become a slightly smaller business (22% of revenue) following the decision to exit the acute care market, and infusion sets contribute 18% of consolidated revenue.
77GF Score
Get the complete analysis for LSE:CTEC
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:CTEC has been successfully added to your 
